{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:54:27Z","timestamp":1789768467348,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31774050"],"award-info":[{"award-number":["31774050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603648"],"award-info":[{"award-number":["81603648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774059"],"award-info":[{"award-number":["81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802605"],"award-info":[{"award-number":["81802605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010225","name":"National Outstanding Youth Foundation of China","doi-asserted-by":"publisher","award":["17JCJQJC46200"],"award-info":[{"award-number":["17JCJQJC46200"]}],"id":[{"id":"10.13039\/501100010225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbrc.2019.03.131","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T16:55:52Z","timestamp":1553705752000},"page":"770-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPAR\u03b1"],"prefix":"10.1016","volume":"512","author":[{"given":"Shu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronglin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-3847","authenticated-orcid":false,"given":"Yuanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanrui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.03.131_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrgastro.2015.12","article-title":"Novel therapeutic targets in primary biliary cirrhosis","volume":"12","author":"Dyson","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5582\/irdr.2014.01018","article-title":"Current research on the treatment of primary sclerosing cholangitis","volume":"4","author":"Ali","year":"2015","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.bbrc.2019.03.131_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.03.131_bib4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","article-title":"Pathogenesis of cholestatic liver disease and therapeutic approaches","volume":"139","author":"Hirschfield","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2019.03.131_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2019.03.131_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.015","article-title":"FXR signaling in metabolic disease","volume":"582","author":"Zhang","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2019.03.131_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00109-005-0678-9","article-title":"Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?","volume":"83","author":"Peters","year":"2005","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbrc.2019.03.131_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MOL.0b013e328332e9ef","article-title":"Combination therapy of statins and fibrates in the management of cardiovascular risk","volume":"20","author":"Fievet","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2010.04512.x","article-title":"Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"33","author":"Levy","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2019.03.131_bib11","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1074\/jbc.C000275200","article-title":"Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7 alpha-hydroxylase","volume":"275","author":"Miyake","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.03.131_bib12","doi-asserted-by":"crossref","first-page":"31416","DOI":"10.1074\/jbc.M204818200","article-title":"Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent","volume":"277","author":"Li","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.03.131_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1017\/S0007114517000149","article-title":"Formononetin, an isoflavone, activates AMP-activated protein kinase\/beta-catenin signalling to inhibit adipogenesis and rescues C57BL\/6 mice from high-fat diet-induced obesity and bone loss","volume":"117","author":"Gautam","year":"2017","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbrc.2019.03.131_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ptr.3641","article-title":"Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL\/6 mice by activating hepatic PPARalpha","volume":"26","author":"Qiu","year":"2012","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2019.03.131_bib15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s10753-013-9700-5","article-title":"Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression","volume":"36","author":"Ma","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.bbrc.2019.03.131_bib16","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/hep.28826","article-title":"Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis","volume":"64","author":"Kulkarni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.03.131_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in\u00a0vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib18","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bph.14156","article-title":"Functional interplay between liver X receptor and AMP-activated protein kinase alpha inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy","volume":"175","author":"Ma","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib19","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/ATVBAHA.114.305116","article-title":"Inhibition of ERK1\/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice","volume":"35","author":"Chen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbrc.2018.10.198","article-title":"Teniposide regulates the phenotype switching of vascular smooth muscle cells in a miR-21-dependent manner","volume":"506","author":"Han","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.03.131_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2008.04.058","article-title":"Peripheral blood monocytes from the decompensated liver cirrhosis could migrate into nude mouse liver with human hepatocyte-markers expression","volume":"371","author":"Yan","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.03.131_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/taap.1993.1049","article-title":"Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration","volume":"119","author":"Kossor","year":"1993","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI117658","article-title":"Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse","volume":"95","author":"Oude Elferink","year":"1995","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.03.131_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0216001","article-title":"Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol","volume":"110","author":"Yu","year":"2002","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.03.131_bib25","doi-asserted-by":"crossref","first-page":"28947","DOI":"10.1074\/jbc.M002782200","article-title":"The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis","volume":"275","author":"Hunt","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.03.131_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","article-title":"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases","volume":"24","author":"Yang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2019.03.131_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1074\/mcp.RA118.000817","article-title":"Celastrol protects from cholestatic liver injury through modulation of SIRT1-FXR signaling","volume":"18","author":"Zhao","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbrc.2019.03.131_bib28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2019.03.131_bib29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2015.08.001","article-title":"Implications of microbiota and bile acid in liver injury and regeneration","volume":"63","author":"Liu","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.03.131_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2019.03.131_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","article-title":"FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states","volume":"10","author":"Kemper","year":"2009","journal-title":"Cell Metabol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1930525X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1930525X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:36:09Z","timestamp":1762094169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1930525X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0006291X1930525X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.131","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPAR\u03b1","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}